Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 26, 1992 - Issue 4
Submit an article Journal homepage
6
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Decrease in Renal Function Following Decreased Fibrinogen and Raised Fibrin Degradation Products in Lupus Nephritis with Nephrotic Syndrome

Yoichi Nagayama2nd Department, Kyoto University Hospital, Japan
,
Hiroo Imura2nd Department, Kyoto University Hospital, Japan
&
Rie Muso3rd Department of Internal Medicine, Kyoto University Hospital, Japan
Pages 387-391 | Received 28 Jun 1991, Accepted 20 Dec 1991, Published online: 15 Feb 2010

REFERENCES

  • BaldwinDS, GluckMC, LowensteinJ, GalloGR. Lupus nephritis: clinical course as related to morphologic forms and their transitions. Am J Med 1977; 62: 12–30.
  • BhuyanUN, MalaviyaAN, DashSC, MalhotraKK. Prognostic significance of renal angiitis in systemic lupus erythematosus (SLE). Clin Nephrol 1983; 20: 109–113.
  • BullBS, SchneidermanMA, BrecherG. Platelet counts with the Coulter counter. Am J Clin Pathol 1965; 44: 678–688.
  • CarvalhoACA, EllmanLL, ColmanRW. A comparison of the staphylococcal clumping test and an agglutination test for detection of fibrinogen degradation products. Am J Clin Pathol 1974; 62: 107–112.
  • CheighJS, KimH, StenzelKH et al. Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evaluation of lupus activity. Am J Kidney Dis 1990; 16: 189–195.
  • ClarksonAR, MacDonaldMK, PetrieJJB, CashJD, RobsonJS. Serum and urinary fibrin/fibrinogen degradation products in glomerulonephritis. Br Med J 1971; 21: 447–451.
  • ClarkWF, LewisML, CameronJS, ParsonsV. Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus. Clin Sci Mol Med 1975; 49: 247–252.
  • GrannisGF. Plasma fibrinogen: determination, normal values, physiopathologic shifts and fluctuations. Clin Chem 1970; 16: 486–494.
  • HydeTA, MellorLD, RaphaelSS. Automation in clinical chemistry. In: Raphael SS ed. Lynch's medical laboratory technology. 3rd ed. Philadelphia: WB Saunders, 1976: 127–144.
  • HydeTA, MellorLD, RaphaelSS. Creatinine clearance. In: RaphaelSS ed. Lynch's medical laboratory technology. 3rd ed. Philadelphia: WB Saunders, 1976: 167–168.
  • KantKS, PollakVE, WeissMA, GlueckHI, MillerMA, HessEV. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 1981; 60: 71–86.
  • KanyereziBR, LwangaSK, BlochKJ. Fibrinogen degradation products in serum and urine of patients with systemic lupus erythematosus: relation to renal disease and pathogenetic mechanism. Athritis Rheum 1971; 14: 267–275.
  • McIntoshRM, KaufmanDB, GriswoldW, SmithFG, VernierRL. Glomerular localization of fibrinogen–clinicopathologic, prognostic and therapeutic considerations. J Chron Dis 1971; 24: 787–800.
  • NossentHC, Henzen-LogmansSC, VroomTM, BerdenJHM, SwaakTJG. Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients. Arthritis Rheum 1990; 33: 970–977.
  • PiraniCL, PollakVE. Systemic lupus erythematosus (SLE) glomerulonephritis (lupus nephritis). In: McCluskeyRT, AndresGA, eds. Immunologically mediated renal diseases. New York: Marcel Dekker, 1978: 19–38.
  • Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA, Lupus Nephritis Collaborative Study Group. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 1989; 36: 891–896.
  • TanEM, CohenAS, FriesJF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
  • WintrobeMM, LeeGR, BoggsDR et al. Acquired coagulation disorders. In: WintrobeMM, LeeGR, BoggsDR et al., eds. Clinical hematology. 8th ed. Philadelphia: Lee & Febiger, 1981: 1206–1246.
  • WintrobeMM, LeeGR, BoggsDR et al. Thrombosis and antithrombotic therapy. In: WintrobeMM, LeeGR, BoggsDR et al., eds. Clinical hematology. 8th ed. Philadelphia: Lee & Febiger, 1981: 1247–1272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.